Octreotide acetate

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

293 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Neuroendocrine tumors	D018358	EFO_1001901	D3A.8	14	32	15	3	9	67
Acromegaly	D000172	—	—	5	10	17	17	9	57
Neoplasms	D009369	—	C80	10	11	6	2	3	29
Carcinoid tumor	D002276	—	D3A.00	9	9	7	1	—	23
Syndrome	D013577	—	—	2	8	4	2	4	18
Hemorrhage	D006470	MP_0001914	R58	1	2	2	4	8	16
Liver cirrhosis	D008103	EFO_0001422	K74.0	1	3	1	5	6	14
Malignant carcinoid syndrome	D008303	—	E34.0	4	6	3	1	—	13
Diarrhea	D003967	—	R19.7	—	3	5	1	3	12
Obesity	D009765	EFO_0001073	E66.9	4	1	—	3	4	12

Show 24 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Pancreatic neoplasms	D010190	EFO_0003860	C25	1	7	3	—	2	13
Carcinoma	D002277	—	C80.0	2	8	3	—	—	12
Stomach neoplasms	D013274	EFO_0003897	C16	1	2	2	—	3	8
Liver diseases	D008107	EFO_0001421	K70-K77	3	3	2	—	1	7
Hepatocellular carcinoma	D006528	—	C22.0	—	3	3	—	1	6
Liver neoplasms	D008113	EFO_1001513	C22.0	—	3	3	—	1	6
Autosomal dominant polycystic kidney	D016891	EFO_1001496	Q61.2	—	4	3	—	1	6
Breast neoplasms	D001943	EFO_0003869	C50	—	1	2	—	2	5
Intestinal neoplasms	D007414	—	C26.0	1	1	2	—	1	5
Colorectal neoplasms	D015179	—	—	—	1	4	—	—	5

Show 29 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Islet cell adenoma	D007516	EFO_0007331	D13.7	2	6	—	—	2	10
Neuroendocrine carcinoma	D018278	—	—	2	6	—	—	—	8
Neuroblastoma	D009447	EFO_0000621	—	3	6	—	—	—	7
Meningioma	D008579	EFO_0003098	D32.9	2	5	—	—	1	7
Gastrointestinal neoplasms	D005770	—	C26.9	3	4	—	—	—	7
Medulloblastoma	D008527	—	—	1	4	—	—	1	5
Recurrence	D012008	—	—	1	2	—	—	2	5
Pheochromocytoma	D010673	—	—	2	2	—	—	—	4
Islet cell carcinoma	D018273	—	C25.4	1	3	—	—	—	4
Esophageal neoplasms	D004938	—	C15	—	1	—	—	3	4

Show 45 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Healthy volunteers/patients	—	—	—	7	—	—	—	—	7
Insulin resistance	D007333	EFO_0002614	E88.819	5	—	—	—	2	7
Non-alcoholic fatty liver disease	D065626	EFO_0003095	K75.81	3	—	—	—	1	4
Fatty liver	D005234	EFO_0003934	—	3	—	—	—	1	4
Central nervous system neoplasms	D016543	—	—	3	—	—	—	—	3
Prediabetic state	D011236	EFO_1001121	R73.03	3	—	—	—	—	3
Nervous system neoplasms	D009423	—	—	2	—	—	—	—	2
Merkel cell carcinoma	D015266	EFO_1001471	C4A	2	—	—	—	—	2
Glucagonoma	D005935	—	—	2	—	—	—	—	2
Hypotension	D007022	EFO_0005251	I95	1	—	—	—	—	1

Show 22 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Malnutrition	D044342	EFO_0008572	E40-E46	—	—	—	—	2	2
Weight loss	D015431	—	—	—	—	—	—	2	2
Postoperative complications	D011183	—	—	—	—	—	—	2	2
Pancreatitis	D010195	EFO_0000278	K85	—	—	—	—	2	2
Hiv infections	D015658	EFO_0000764	B20	—	—	—	—	2	2
Immunologic deficiency syndromes	D007153	—	D84.9	—	—	—	—	2	2
Myocarditis	D009205	—	I51.4	—	—	—	—	1	1
Brain neoplasms	D001932	EFO_0003833	C71	—	—	—	—	1	1
Glioblastoma	D005909	EFO_0000515	—	—	—	—	—	1	1
Glioma	D005910	EFO_0000520	—	—	—	—	—	1	1